Clostridioides Difficile Infection research hub
3 indexed studies · 3 currently recruiting
- recruitingPHASE2
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
This study is testing a new medicine, AZD5148, to see if it can stop C. difficile infections from coming back. It’s for adults who have recently had this infection. Half the participants will get the study medicine, and half will get a dummy treatment to compare.
United States · Australia · Canada - recruitingPHASE2, PHASE3
Secondary Prevention of Clostridioides Difficile Using Vancomycin
This study looks at whether a medicine called vancomycin, given after a C. difficile infection, can stop it from coming back, especially when you need to take other antibiotics. We want to see if this helps prevent repeat infections.
Canada - recruitingPHASE3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
This study is testing a new medicine, VE303, to prevent repeated C. diff infections. C. diff causes severe diarrhoea. We want to see if VE303 is safe and helps stop the infection from coming back after standard treatment.
United States · Australia · Belgium